Colleen’s Dream Foundation Donates $10,000 to Johns Hopkins Medicine for Ovarian Cancer Research
PR Web |
Colleen's
According to Cundiff, this is the second year in a row Colleen's
"One of the main goals of Colleen's
Cundiff says this year's grant to
According to Dr.
"Prevention is probably the most effective way of reducing morbidity and mortality from ovarian cancer," says Kurman. "Dr. Kashima's research, which focuses on re-purposing a drug that has been used for many years for use in preventing ovarian cancer, would be an important breakthrough."
Kurman adds the grant from Colleen's
"In his future work, Dr. Kashima will study the molecular mechanisms underlying how statins prevent the development of ovarian cancer," says Kurman. "These studies will provide the biological basis for the development of clinical trials to determine whether statins can indeed prevent ovarian cancer in high-risk women."
Cundiff, who is the kicker for the
"Dustin and his team at
Gaskey says it was an easy decision to partner with Cundiff and Colleen's
"As a father, a husband, a brother, and a son…participating with Colleen's
ABOUT OVARIAN CANCER:
Ovarian cancer is often referred to as "the silent killer" because many women do not discover their disease until it is in the late stages, which leads to many women succumbing to the disease within a short period of time. Unlike cervical or breast cancer, ovarian cancer does not have a standardized early detection procedure. When it comes to women's health, ovarian cancer proves to be one of the deadliest diseases.
ABOUT COLLEEN'S DREAM FOUNDATION:
Colleen's
Colleen's
Go here to find out more about Colleen's
Colleen's
Read the full story at http://www.prweb.com/releases/2014/06/prweb11958034.htm
Copyright: | (c) 2014 PRWEB.COM Newswire |
Wordcount: | 659 |
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News